世界の化学医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chemotherapy Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5655
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、化学医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（代謝拮抗剤、植物アルカロイド、アルキル化剤、抗腫瘍抗生物質）、用途別市場規模（経口、静脈内）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・化学医薬品の市場動向
・企業の競争状況、市場シェア
・化学医薬品の種類別市場規模と予測2016-2027（代謝拮抗剤、植物アルカロイド、アルキル化剤、抗腫瘍抗生物質）
・化学医薬品の用途別市場規模と予測2016-2027（経口、静脈内）
・化学医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・化学医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・化学医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・化学医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・化学医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Eli Lilly、CELGENE、Bristol-Myers Squibb、Merck、GlaxoSmithKline、Novartis、Sanofi、Teva Pharmaceuticals Industries）
・結論

Chemotherapy is the use of any drug to treat any disease. But to most people, the wordchemotherapy means drugs used for cancer treatment.

Market Analysis and Insights: Global Chemotherapy Drug Market
The global Chemotherapy Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chemotherapy Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chemotherapy Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chemotherapy Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chemotherapy Drug market.

Global Chemotherapy Drug Scope and Market Size
Chemotherapy Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antimetabolites
Plant Alkaloids
Alkylating Agents
Antitumor Antibiotics

Segment by Application
Oral
Intravenous

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Eli Lilly
CELGENE
Bristol-Myers Squibb
Merck
GlaxoSmithKline
Novartis
Sanofi
Teva Pharmaceuticals Industries

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotherapy Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antimetabolites
1.2.3 Plant Alkaloids
1.2.4 Alkylating Agents
1.2.5 Antitumor Antibiotics
1.3 Market by Application
1.3.1 Global Chemotherapy Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oral
1.3.3 Intravenous
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chemotherapy Drug Market Perspective (2016-2027)
2.2 Chemotherapy Drug Growth Trends by Regions
2.2.1 Chemotherapy Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chemotherapy Drug Historic Market Share by Regions (2016-2021)
2.2.3 Chemotherapy Drug Forecasted Market Size by Regions (2022-2027)
2.3 Chemotherapy Drug Industry Dynamic
2.3.1 Chemotherapy Drug Market Trends
2.3.2 Chemotherapy Drug Market Drivers
2.3.3 Chemotherapy Drug Market Challenges
2.3.4 Chemotherapy Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy Drug Players by Revenue
3.1.1 Global Top Chemotherapy Drug Players by Revenue (2016-2021)
3.1.2 Global Chemotherapy Drug Revenue Market Share by Players (2016-2021)
3.2 Global Chemotherapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chemotherapy Drug Revenue
3.4 Global Chemotherapy Drug Market Concentration Ratio
3.4.1 Global Chemotherapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy Drug Revenue in 2020
3.5 Chemotherapy Drug Key Players Head office and Area Served
3.6 Key Players Chemotherapy Drug Product Solution and Service
3.7 Date of Enter into Chemotherapy Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chemotherapy Drug Breakdown Data by Type
4.1 Global Chemotherapy Drug Historic Market Size by Type (2016-2021)
4.2 Global Chemotherapy Drug Forecasted Market Size by Type (2022-2027)

5 Chemotherapy Drug Breakdown Data by Application
5.1 Global Chemotherapy Drug Historic Market Size by Application (2016-2021)
5.2 Global Chemotherapy Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chemotherapy Drug Market Size (2016-2027)
6.2 North America Chemotherapy Drug Market Size by Type
6.2.1 North America Chemotherapy Drug Market Size by Type (2016-2021)
6.2.2 North America Chemotherapy Drug Market Size by Type (2022-2027)
6.2.3 North America Chemotherapy Drug Market Size by Type (2016-2027)
6.3 North America Chemotherapy Drug Market Size by Application
6.3.1 North America Chemotherapy Drug Market Size by Application (2016-2021)
6.3.2 North America Chemotherapy Drug Market Size by Application (2022-2027)
6.3.3 North America Chemotherapy Drug Market Size by Application (2016-2027)
6.4 North America Chemotherapy Drug Market Size by Country
6.4.1 North America Chemotherapy Drug Market Size by Country (2016-2021)
6.4.2 North America Chemotherapy Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chemotherapy Drug Market Size (2016-2027)
7.2 Europe Chemotherapy Drug Market Size by Type
7.2.1 Europe Chemotherapy Drug Market Size by Type (2016-2021)
7.2.2 Europe Chemotherapy Drug Market Size by Type (2022-2027)
7.2.3 Europe Chemotherapy Drug Market Size by Type (2016-2027)
7.3 Europe Chemotherapy Drug Market Size by Application
7.3.1 Europe Chemotherapy Drug Market Size by Application (2016-2021)
7.3.2 Europe Chemotherapy Drug Market Size by Application (2022-2027)
7.3.3 Europe Chemotherapy Drug Market Size by Application (2016-2027)
7.4 Europe Chemotherapy Drug Market Size by Country
7.4.1 Europe Chemotherapy Drug Market Size by Country (2016-2021)
7.4.2 Europe Chemotherapy Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chemotherapy Drug Market Size (2016-2027)
8.2 Asia-Pacific Chemotherapy Drug Market Size by Type
8.2.1 Asia-Pacific Chemotherapy Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chemotherapy Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chemotherapy Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Chemotherapy Drug Market Size by Application
8.3.1 Asia-Pacific Chemotherapy Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chemotherapy Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chemotherapy Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Chemotherapy Drug Market Size by Region
8.4.1 Asia-Pacific Chemotherapy Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chemotherapy Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chemotherapy Drug Market Size (2016-2027)
9.2 Latin America Chemotherapy Drug Market Size by Type
9.2.1 Latin America Chemotherapy Drug Market Size by Type (2016-2021)
9.2.2 Latin America Chemotherapy Drug Market Size by Type (2022-2027)
9.2.3 Latin America Chemotherapy Drug Market Size by Type (2016-2027)
9.3 Latin America Chemotherapy Drug Market Size by Application
9.3.1 Latin America Chemotherapy Drug Market Size by Application (2016-2021)
9.3.2 Latin America Chemotherapy Drug Market Size by Application (2022-2027)
9.3.3 Latin America Chemotherapy Drug Market Size by Application (2016-2027)
9.4 Latin America Chemotherapy Drug Market Size by Country
9.4.1 Latin America Chemotherapy Drug Market Size by Country (2016-2021)
9.4.2 Latin America Chemotherapy Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chemotherapy Drug Market Size (2016-2027)
10.2 Middle East & Africa Chemotherapy Drug Market Size by Type
10.2.1 Middle East & Africa Chemotherapy Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chemotherapy Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chemotherapy Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Chemotherapy Drug Market Size by Application
10.3.1 Middle East & Africa Chemotherapy Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chemotherapy Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chemotherapy Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Chemotherapy Drug Market Size by Country
10.4.1 Middle East & Africa Chemotherapy Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chemotherapy Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Chemotherapy Drug Introduction
11.1.4 Pfizer Revenue in Chemotherapy Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Chemotherapy Drug Introduction
11.2.4 Eli Lilly Revenue in Chemotherapy Drug Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 CELGENE
11.3.1 CELGENE Company Details
11.3.2 CELGENE Business Overview
11.3.3 CELGENE Chemotherapy Drug Introduction
11.3.4 CELGENE Revenue in Chemotherapy Drug Business (2016-2021)
11.3.5 CELGENE Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Chemotherapy Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Chemotherapy Drug Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Chemotherapy Drug Introduction
11.5.4 Merck Revenue in Chemotherapy Drug Business (2016-2021)
11.5.5 Merck Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chemotherapy Drug Introduction
11.6.4 GlaxoSmithKline Revenue in Chemotherapy Drug Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Chemotherapy Drug Introduction
11.7.4 Novartis Revenue in Chemotherapy Drug Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Chemotherapy Drug Introduction
11.8.4 Sanofi Revenue in Chemotherapy Drug Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceuticals Industries
11.9.1 Teva Pharmaceuticals Industries Company Details
11.9.2 Teva Pharmaceuticals Industries Business Overview
11.9.3 Teva Pharmaceuticals Industries Chemotherapy Drug Introduction
11.9.4 Teva Pharmaceuticals Industries Revenue in Chemotherapy Drug Business (2016-2021)
11.9.5 Teva Pharmaceuticals Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chemotherapy Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antimetabolites
Table 3. Key Players of Plant Alkaloids
Table 4. Key Players of Alkylating Agents
Table 5. Key Players of Antitumor Antibiotics
Table 6. Global Chemotherapy Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chemotherapy Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chemotherapy Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chemotherapy Drug Market Share by Regions (2016-2021)
Table 10. Global Chemotherapy Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chemotherapy Drug Market Share by Regions (2022-2027)
Table 12. Chemotherapy Drug Market Trends
Table 13. Chemotherapy Drug Market Drivers
Table 14. Chemotherapy Drug Market Challenges
Table 15. Chemotherapy Drug Market Restraints
Table 16. Global Chemotherapy Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chemotherapy Drug Market Share by Players (2016-2021)
Table 18. Global Top Chemotherapy Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Drug as of 2020)
Table 19. Ranking of Global Top Chemotherapy Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chemotherapy Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chemotherapy Drug Product Solution and Service
Table 23. Date of Enter into Chemotherapy Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chemotherapy Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chemotherapy Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Chemotherapy Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chemotherapy Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chemotherapy Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chemotherapy Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Chemotherapy Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chemotherapy Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chemotherapy Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chemotherapy Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chemotherapy Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chemotherapy Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chemotherapy Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chemotherapy Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chemotherapy Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chemotherapy Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chemotherapy Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chemotherapy Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chemotherapy Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chemotherapy Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chemotherapy Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chemotherapy Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chemotherapy Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chemotherapy Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chemotherapy Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chemotherapy Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chemotherapy Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chemotherapy Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chemotherapy Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chemotherapy Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chemotherapy Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chemotherapy Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chemotherapy Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chemotherapy Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chemotherapy Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chemotherapy Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chemotherapy Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chemotherapy Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Chemotherapy Drug Product
Table 66. Pfizer Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Chemotherapy Drug Product
Table 71. Eli Lilly Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. CELGENE Company Details
Table 74. CELGENE Business Overview
Table 75. CELGENE Chemotherapy Drug Product
Table 76. CELGENE Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 77. CELGENE Recent Development
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Chemotherapy Drug Product
Table 81. Bristol-Myers Squibb Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Chemotherapy Drug Product
Table 86. Merck Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Chemotherapy Drug Product
Table 91. GlaxoSmithKline Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Chemotherapy Drug Product
Table 96. Novartis Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Teva Pharmaceuticals Industries Company Details
Table 103. Teva Pharmaceuticals Industries Business Overview
Table 104. Teva Pharmaceuticals Industries Chemotherapy Drug Product
Table 105. Teva Pharmaceuticals Industries Revenue in Chemotherapy Drug Business (2016-2021) & (US$ Million)
Table 106. Teva Pharmaceuticals Industries Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotherapy Drug Market Share by Type: 2020 VS 2027
Figure 2. Antimetabolites Features
Figure 3. Plant Alkaloids Features
Figure 4. Alkylating Agents Features
Figure 5. Antitumor Antibiotics Features
Figure 6. Global Chemotherapy Drug Market Share by Application: 2020 VS 2027
Figure 7. Oral Case Studies
Figure 8. Intravenous Case Studies
Figure 9. Chemotherapy Drug Report Years Considered
Figure 10. Global Chemotherapy Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chemotherapy Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chemotherapy Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Chemotherapy Drug Market Share by Regions (2022-2027)
Figure 14. Global Chemotherapy Drug Market Share by Players in 2020
Figure 15. Global Top Chemotherapy Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chemotherapy Drug Revenue in 2020
Figure 17. Global Chemotherapy Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Chemotherapy Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chemotherapy Drug Market Share by Type (2016-2027)
Figure 21. North America Chemotherapy Drug Market Share by Application (2016-2027)
Figure 22. North America Chemotherapy Drug Market Share by Country (2016-2027)
Figure 23. United States Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chemotherapy Drug Market Share by Type (2016-2027)
Figure 27. Europe Chemotherapy Drug Market Share by Application (2016-2027)
Figure 28. Europe Chemotherapy Drug Market Share by Country (2016-2027)
Figure 29. Germany Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chemotherapy Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chemotherapy Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chemotherapy Drug Market Share by Region (2016-2027)
Figure 39. China Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chemotherapy Drug Market Share by Type (2016-2027)
Figure 47. Latin America Chemotherapy Drug Market Share by Application (2016-2027)
Figure 48. Latin America Chemotherapy Drug Market Share by Country (2016-2027)
Figure 49. Mexico Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chemotherapy Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chemotherapy Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chemotherapy Drug Market Share by Country (2016-2027)
Figure 55. Turkey Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chemotherapy Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 60. CELGENE Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 66. Teva Pharmaceuticals Industries Revenue Growth Rate in Chemotherapy Drug Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3999 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、化学療法誘発性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年）

Global Hypothyroidism Drug Market Size, Status and Forecast 2021-2027
QFJ1-4342 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、甲状腺機能低下症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、診療所、その他）、主要地域...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年）

Global Anticholinergic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5583 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗コリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Hepatic Porphyria Drug Market Size, Status and Forecast 2021-2027
QFJ1-5564 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、急性肝性ポルフィリン症用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350 Mg、313 Mg）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメ...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のデシタビン薬市場規模・現状・予測（2021年-2027年）

Global Decitabine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5691 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、デシタビン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダコゲン、ジェネリック）、用途別市場規模（病院、ドラックストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年） Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal c…
化学療法による好中球減少薬のグローバル市場調査 2019年 The global Chemotherapy Induced Neutropenia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chemotherapy Induced Neutropenia Drug volume and value at global level, regional level and company le…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界の植物抽出薬市場規模・現状・予測（2021年-2027年） A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans. Market Analysis and Insights: Global Plant Extract Drug Market The global Plant Extract Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in…
世界の植物性薬市場規模・現状・予測（2021年-2027年） A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans. Market Analysis and Insights: Global Plant Derivative Drug Market The global Plant Derivative Drug market size is projected to reach US$ XX million by 2027, from US$ XX mill…